CIK 0001287098
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522210438
- Phone
- +1 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | DOUGLAS RICHARD Director | Grant or award | +30,421 | 260,998 | ||
| 2026-06-17 | DOUGLAS RICHARD Director | Grant or award · Stock Option (right to buy) | +49,579 | 49,579 | ||
| 2025-08-13 | DOUGLAS RICHARD Director | Purchase | +80,000 | $1.39 | $111K | 230,577 |
| 2025-06-18 | DOUGLAS RICHARD Director | Grant or award | +29,210 | 150,577 | ||
| 2025-06-18 | DOUGLAS RICHARD Director | Grant or award · Stock Option (right to buy) | +50,790 | 50,790 | ||
| 2024-06-11 | DOUGLAS RICHARD Director | Grant or award | +21,367 | 121,367 | ||
| 2024-06-11 | DOUGLAS RICHARD Director | Grant or award · Stock Option (right to buy) | +40,701 | 40,701 | ||
| 2023-06-22 | DOUGLAS RICHARD Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-03-29 | DOUGLAS RICHARD Director | Purchase | +80,000 | $4.32 | $345K | 100,000 |
| 2022-06-29 | DOUGLAS RICHARD Director | Grant or award · Stock Option (right to buy) | +26,900 | 26,900 | ||
| 2021-11-22 | DOUGLAS RICHARD Director | Purchase | +20,000 | $11.12 | $222K | 20,000 |
| 2021-08-09 | DOUGLAS RICHARD Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 1 of 1 · 12 trades